Founded with a commitment to ethical innovation, Agathos Biologics is a biotechnology company focused on developing transformative scientific solutions. The company's core mission is to advance "Good Science without compromise," ensuring that their work adheres to high ethical standards. Agathos Biologics offers a range of services including custom AAV (Adeno-Associated Virus) production, analytical services, and proprietary cell lines like AE1-BHK. Their market focus spans various sectors in biotechnology, aiming to provide cutting-edge solutions for complex biological challenges.
Agathos Biologics has garnered attention for its strong ethical framework and impactful scientific contributions. The management team comprises experienced professionals dedicated to fostering innovation with integrity. Notable achievements include the development of advanced cell lines and custom viral vectors that have significant implications for gene therapy and other medical applications. The company's emphasis on ethical practices has set a benchmark in the biotech industry, promoting responsible science that aims to improve global health outcomes.